Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase src'

Search results for: 'research area tyrosine kinase src'

Items 151-160 of 285

Page
per page
  1. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  2. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
      ≥36.6 mg/mL
  3. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL
  4. AKT inhibitor VIII
    A3149 AKT inhibitor VIII
     2 Citation
    Target: Akt
    Summary: Allosteric Akt kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL
  5. Axitinib (AG 013736)
    A8370 Axitinib (AG 013736)
     1 Citation
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR1/ c-Kit inhibitor
      insoluble in H2O; ≥19.3 mg/mL
  6. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
      insoluble in EtOH; ≥10.62 mg/mL
  7. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  8. AMG 925
    B3277 AMG 925
    Target: Cyclin-Dependent Kinases|FLT3
    Summary: FLT3/CDK4 inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  9. Sotrastaurin (AEB071)
    A8525 Sotrastaurin (AEB071)
    Target: PKC
    Summary: PKC inhibitor
      ≥21.9 mg/mL
  10. GF 109203X
    A8342 GF 109203X
     1 Citation
    Target: PKC
    Summary: Protein kinase C,MLCK,PKG and PKA inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL

Items 151-160 of 285

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 282item
  2. Natural Products 1 item
  3. Lab Reagents 1 item
Specificity
  1. Selective 210item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 22item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 14item
  5. Raf 10item
  6. Aurora Kinases 18item
  7. CSF-1R 4item
  8. mTOR 7item
  9. FLT3 13item
  10. GSK-3 8item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 2item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 1 item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 1 item
  23. SGK 1 item
  24. Bcr-Abl 11item
  25. MEK 3item
  26. FGFR 12item
  27. Pim 3item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. MET 5item
  30. Src 15item
  31. Trk Receptors 2item
  32. STAT 3item
  33. EGFR 16item
  34. ROCK 5item
  35. BTK 1 item
  36. PAK 3item
  37. FAK 4item
  38. BMP and Other Activin Receptors 2item
  39. JAK 14item
  40. Syk 5item
  41. DNA-PK 4item
  42. AMPK 2item
  43. PDHK 1 item
  44. Cytochrome P450 (CYP450) 1 item
  45. ErbB 5item
  46. S6 kinases 1 item
  47. Adenosine Kinases 2item
  48. ERK 4item
  49. c-MET 5item
  50. PKC 11item
  51. Ubiquitin-specific proteases 1 item
  52. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  53. Lyn 2item
  54. HER2 2item
  55. Pyk2 3item
  56. LRRK2 5item
  57. Insulin and Insulin-like Receptors 3item
  58. ALK 6item
  59. ROS1 1 item
  60. Sphingosine kinases (SphKs) 2item
  61. PKG 1 item
  62. PKA 4item
  63. Myosin light chain kinases (MLCKs) 1 item
  64. MELK 1 item
  65. Insulin-like growth factors (IGFs) 1 item
  66. MK2 2item
  67. Fatty-acid-binding proteins (FABPs) 1 item
  68. Angiotensin-Converting Enzymes (ACEs) 1 item
  69. Tie-2 2item
  70. RSK 2item
  71. phosphatases 1 item
  72. ATM/ATR 2item
  73. Farnesyl Diphosphate Synthases 1 item
  74. CK2 2item
  75. HIPK2 1 item
  76. HIPK3 1 item
  77. P2X Receptors 1 item
  78. Histamine H1 Receptors 1 item
  79. P110 1 item
  80. Hck 2item
  81. MNK 1 item
  82. 5-Lipoxygenases 1 item
  83. Insulin Receptors 1 item
  84. IRG-1R 1 item
  85. Cdc2-like kinase (Clk) 1 item
  86. eEF-2 1 item
  87. Cdc7 1 item
  88. ZAP-70 1 item
  89. c-RET 3item
  90. p70 rsk 2item
  91. VEGFR3/FLT4 1 item
  92. NTRK1/TRKA 1 item
  93. CSF-1R/c-Fms 1 item
  94. TAM kinase 1 item
  95. KDR 1 item
  96. Fyn kinase 1 item
  97. AXL 1 item
  98. c-Fms tyrosine kinase 1 item
  99. insulin 1 item
  100. MSK 1 item
  101. Lyn kinase 1 item
  102. Mer tyrosine kinase 1 item
  103. ErbB-2 1 item
  104. PDK-1 1 item
  105. Histone Acetyltransferases (HATs) 1 item
  106. Prk 1 item
  107. ITK 1 item
  108. NUAK 1 item
  109. DCLK2 1 item
  110. PTK 1 item
  111. phosphatidylinositol kinase 1 item
  112. Flk1 2item
  113. Protein Tyrosine Phosphatases 1 item
  114. alkaline phosphatases 1 item
  115. ATPases 1 item
  116. glutamate release 1 item
  117. FGR 1 item
  118. YES 2item
  119. Fyn 2item
  120. ARG 1 item
  121. TRPC channel 1 item
  122. PKD 1 item
  123. Pyruvate kinases 1 item
  124. enoyl-acyl-carrier protein reductase 1 item
  125. Rho-kinase 1 item
  126. tropomyosin receptor kinase 1 item
  127. SK 1 item
  128. PPK 1 item
  129. c-Syk 1 item
  130. CDK1/CyclinB 1 item
  131. PIM1 kinase 1 item
  132. phospholipase A2 1 item
  133. PIKfyve 1 item
  134. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 15item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 42item
  9. Cancer 186item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 18item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 18item
  17. Glioblastoma 17item
  18. Glioma 6item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 3item
  24. Leukemia 8item
  25. Liver Cancer 3item
  26. Lung Cancer 14item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 11item
  31. Multiple Myeloma 4item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 5item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 14item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 14item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 3item